Stillger, M.N., Chen, C.- yi, Lai, Z.W., Li, M., Schäfer, A., Pagenstecher, A., Nimsky, C., Bartsch, J.W. und Schilling, O. (2023) Changes in calpain-2 expression during glioblastoma progression predisposes tumor cells to temozolomide resistance by minimizing DNA damage and p53-dependent apoptosis [cd]. Freiburg: Universität. doi:10.1186/s12935-023-02889-8.

Stillger, Maren Nicole, Chia-yi Chen, Zon Weng Lai, Mujia Li, Agnes Schäfer, Axel Pagenstecher, Christopher Nimsky, Jörg Walter Bartsch, und Oliver Schilling. Changes in calpain-2 expression during glioblastoma progression predisposes tumor cells to temozolomide resistance by minimizing DNA damage and p53-dependent apoptosis. Cd. Freiburg: Universität, [2023?], Freiburg: Universität, [2023?]. https://doi.org/10.1186/s12935-023-02889-8.

Stillger, M. N., Chen, C.- yi, Lai, Z. W., Li, M., Schäfer, A., Pagenstecher, A., Nimsky, C., Bartsch, J. W., & Schilling, O. (ca. 2023). Changes in calpain-2 expression during glioblastoma progression predisposes tumor cells to temozolomide resistance by minimizing DNA damage and p53-dependent apoptosis [Cd]. Universität. https://doi.org/10.1186/s12935-023-02889-8

Stillger, M. N., C.- yi Chen, Z. W. Lai, M. Li, A. Schäfer, A. Pagenstecher, C. Nimsky, J. W. Bartsch, und O. Schilling. Changes in calpain-2 expression during glioblastoma progression predisposes tumor cells to temozolomide resistance by minimizing DNA damage and p53-dependent apoptosis. cd, Universität, 2023, https://doi.org/10.1186/s12935-023-02889-8.

STILLGER, Maren Nicole, Chia-yi CHEN, Zon Weng LAI, Mujia LI, Agnes SCHÄFER, Axel PAGENSTECHER, Christopher NIMSKY, Jörg Walter BARTSCH und Oliver SCHILLING, 2023. Changes in calpain-2 expression during glioblastoma progression predisposes tumor cells to temozolomide resistance by minimizing DNA damage and p53-dependent apoptosis. Freiburg: Universität